Background/aim: The validity of laparoscopic distal pancreatectomy in left-sided pancreatic adenocarcinoma (PDAC) is still unclear. However, a meticulous surgical dissection through a "no-touch" technique might allow a radical oncological resection with minimal risk of tumor dissemination and seeding. This study aimed to evaluate the oncological outcomes of the laparoscopic "no touch" technique versus the "touch" technique. Patients and methods: From 2001 to 2020, we retrospectively analyzed 45 patients undergoing laparoscopic distal pancreatectomy (LDP) for PDAC in two centers. Factors associated with overall (OS), disease-free survival (DFS) and time to recurrence (TTR) were identified. Results: The OS rates in the 'no-touch' and 'touch' groups were 95% vs. 78% (1-year OS); 50% vs. 50% (3-year OS), respectively (p=0.60). The DFS rates in the 'no-touch' and 'touch' groups were 72 % vs. 57% (1-year DFS); 32% vs. 28% (3-year DFS), respectively (p=0.11). The TTR rates in the 'no-touch' and 'touch' groups were 77% vs. 61% (1-year TTR); 54% vs. 30% (3-year TTR); 46% vs. 11% (5-year TTR); respectively (p=0.02) In multivariate analysis the only factors were Touch technique [odds ratio (OR)=2.62, p=0.02] and lymphovascular emboli (OR=4.8; p=0.002). Conclusion: We advise the 'no-touch' technique in patients with resectable PDAC in the pancreatic body and tail. Although this study does not provide definitive proof of superiority, no apparent downsides are present for the 'no-touch' technique in this setting although there could be oncological benefits.

Oncological outcome after laparoscopic 'No-touch' RAMPS versus 'Touch' left pancreatectomy for pancreatic adenocarcinoma / Mazzotta, Alessandro D; VAN Bodegraven, Eduard A; Petrucciani, Niccolo; Usai, Sofia; Carneiro, Adriano Costa; Tribillon, Ecoline; Ferraz, Jean Marc; Busch, Olivier R; Gayet, Brice; Besselink, Marc G; Soubrane, Olivier. - In: ANTICANCER RESEARCH. - ISSN 1791-7530. - 43:11(2023), pp. 4983-4991. [10.21873/anticanres.16697]

Oncological outcome after laparoscopic 'No-touch' RAMPS versus 'Touch' left pancreatectomy for pancreatic adenocarcinoma

Mazzotta, Alessandro D
;
Petrucciani, Niccolo;Usai, Sofia;
2023

Abstract

Background/aim: The validity of laparoscopic distal pancreatectomy in left-sided pancreatic adenocarcinoma (PDAC) is still unclear. However, a meticulous surgical dissection through a "no-touch" technique might allow a radical oncological resection with minimal risk of tumor dissemination and seeding. This study aimed to evaluate the oncological outcomes of the laparoscopic "no touch" technique versus the "touch" technique. Patients and methods: From 2001 to 2020, we retrospectively analyzed 45 patients undergoing laparoscopic distal pancreatectomy (LDP) for PDAC in two centers. Factors associated with overall (OS), disease-free survival (DFS) and time to recurrence (TTR) were identified. Results: The OS rates in the 'no-touch' and 'touch' groups were 95% vs. 78% (1-year OS); 50% vs. 50% (3-year OS), respectively (p=0.60). The DFS rates in the 'no-touch' and 'touch' groups were 72 % vs. 57% (1-year DFS); 32% vs. 28% (3-year DFS), respectively (p=0.11). The TTR rates in the 'no-touch' and 'touch' groups were 77% vs. 61% (1-year TTR); 54% vs. 30% (3-year TTR); 46% vs. 11% (5-year TTR); respectively (p=0.02) In multivariate analysis the only factors were Touch technique [odds ratio (OR)=2.62, p=0.02] and lymphovascular emboli (OR=4.8; p=0.002). Conclusion: We advise the 'no-touch' technique in patients with resectable PDAC in the pancreatic body and tail. Although this study does not provide definitive proof of superiority, no apparent downsides are present for the 'no-touch' technique in this setting although there could be oncological benefits.
2023
laparoscopy; outcome; pancreatic adenocarcinoma; survival
01 Pubblicazione su rivista::01a Articolo in rivista
Oncological outcome after laparoscopic 'No-touch' RAMPS versus 'Touch' left pancreatectomy for pancreatic adenocarcinoma / Mazzotta, Alessandro D; VAN Bodegraven, Eduard A; Petrucciani, Niccolo; Usai, Sofia; Carneiro, Adriano Costa; Tribillon, Ecoline; Ferraz, Jean Marc; Busch, Olivier R; Gayet, Brice; Besselink, Marc G; Soubrane, Olivier. - In: ANTICANCER RESEARCH. - ISSN 1791-7530. - 43:11(2023), pp. 4983-4991. [10.21873/anticanres.16697]
File allegati a questo prodotto
File Dimensione Formato  
Mazzotta_Oncological-outcome_2024.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1696565
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact